NuGen Medical Devices Inc. NGMDF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -172.01% | -464.31% | -47.24% | 74.11% | 57.54% |
| Total Depreciation and Amortization | -35.59% | 11.64% | 4.92% | -1.38% | -7.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 440.54% | 369.49% | 1,457.25% | -165.22% | -176.66% |
| Change in Net Operating Assets | 82.43% | 96.98% | 23.81% | -200.07% | -153.52% |
| Cash from Operations | 18.79% | 19.53% | 25.10% | -64.85% | -58.53% |
| Capital Expenditure | -2,351.35% | -5,254.05% | -2,325.68% | -2,722.73% | -236.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -427.76% | -8,588.89% | -3,175.00% | -3,183.33% | -1.83% |
| Cash from Investing | -735.21% | -5,615.66% | -2,444.19% | -2,885.29% | -14.60% |
| Total Debt Issued | -- | -- | -- | -100.00% | 51.98% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -100.00% | -100.00% | -95.10% | -43.92% | -74.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -100.00% | -99.49% | -95.84% | 391.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.99% | -173.90% | -156.92% | -164.22% | 593.56% |